Clinical meaning
Chronic inflammatory states encompass conditions where sustained immune activation drives multisystem damage. Autoimmune conditions (RA, SLE, IBD) involve loss of immune tolerance with autoreactive T-cells and autoantibodies attacking self-tissue. Metabolic inflammation (metainflammation) in obesity involves adipocyte hypertrophy triggering macrophage infiltration and cytokine release (TNF-α, IL-6, MCP-1). These conditions share common downstream effects: endothelial dysfunction, insulin resistance, accelerated atherosclerosis, and increased thrombotic risk. The NP must manage both the primary inflammatory condition and its systemic cardiovascular and metabolic consequences.
Diagnosis & workup
Diagnostics & workup: - Serial CRP and ESR for disease activity monitoring - Disease-specific markers (RF, anti-CCP for RA; ANA, anti-dsDNA for SLE; ANCA for vasculitis) - Cardiovascular risk assessment (lipid panel, coronary artery calcium score) - HbA1C and fasting glucose for metabolic surveillance - Complete metabolic panel for organ function - Bone density screening for patients on chronic steroids - Drug-specific monitoring labs (CBC, LFTs for methotrexate; renal function for NSAIDs)